Clarus Therapeutics Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Clarus Therapeutics Holdings in the second quarter 2022?
Due to the lack of equity, it was not possible to calculate Clarus Therapeutics Holdings Inc.'s return on equity (ROE) in its second quarter 2022

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-35	-43	-43	-36	-28
Return On Equity (TTM)	-	-	-	-	-
CRXT's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-13	-30	-16	-26	-355
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to CRXT Management Effectiveness >> CRXT's 5 Years Annual ROE >> Compare CRXT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

CRXT Annual Return On Equity	(Dec 31 2021) 2021	(Dec 31 2020) 2020
Total Equity in Millions	-16	-326	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-40	4	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

Back to CRXT Management Effectiveness >> CRXT's 5 Years Annual ROE >> Compare CRXT ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CRXT's' Return on Equity at Yahoo Finance
CRXT's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CRXT's Competitors
Subscribers only: Roe for Clarus Therapeutics Holdings's Suppliers
Subscribers only: Return On Equity for CRXT's Customers

Companies with similar Return On Equity at Jun 30 2022, within Healthcare Sector	ROE
Clene Inc	313.71 %
Waters Corporation	196.42 %
Molecular Templates Inc	164.06 %
Amgen Inc	144.12 %
Halozyme Therapeutics Inc	141.91 %
Effector Therapeutics Inc	121.96 %
Aptevo Therapeutics Inc	109.76 %
Avid Bioservices Inc	106.62 %
Idexx Laboratories Inc	104.46 %
Davita Inc	104.44 %
Moderna Inc	94.76 %
Dynavax Technologies Corporation	93.16 %
Journey Medical Corp	85.14 %
Cartesian Therapeutics Inc	85.07 %
Abbvie Inc	84.29 %
Biomx Inc	83.21 %
Vicarious Surgical Inc	82.59 %
Maravai Lifesciences Holdings Inc	79.73 %
Sensus Healthcare Inc	74.85 %
Tenet Healthcare Corp	74.11 %
Vir Biotechnology Inc	68.86 %
Biofrontera Inc	65.87 %
Vivos Therapeutics Inc	65.69 %
Eli Lilly And Company	64.62 %
Iteos Therapeutics Inc	60.26 %
Oncotelic Therapeutics Inc	59.84 %
Vyne Therapeutics Inc	54.91 %
Siga Technologies Inc	48.79 %
REST EZ Inc.	48.50 %
Glucotrack Inc	47.72 %

Date modified: 2026-09-26T07:40:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.